Carcinoma, Papillary
Showing 1 - 25 of 8,345
Asymptomatic Papillary Microcarcinomas on Patient Survival
Active, not recruiting
- Papillary Carcinoma
- Questionnaire
-
Toulouse, FranceUHToulouse
May 15, 2023
Papillary Thyroid Microcarcinoma Trial in Los Angeles (Active Surveillance)
Recruiting
- Papillary Thyroid Microcarcinoma
- Active Surveillance
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 5, 2022
Papillary Thyroid Carcinoma, Thermal Ablation Trial in Beijing (No Intervention)
Recruiting
- Papillary Thyroid Carcinoma
- Thermal Ablation
- No Intervention
-
Beijing, ChinaBeijing Friendship Hospital
Jul 19, 2023
Papillary Thyroid Microcarcinoma, Thyroid, Thyroid Cancer Trial in New York (Percutaneous Laser Ablation (PLA))
Recruiting
- Papillary Thyroid Microcarcinoma
- +2 more
- Percutaneous Laser Ablation (PLA)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 14, 2022
Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)
Not yet recruiting
- Papillary Renal Cell Carcinoma
- Pembrolizumab
- Placebo
- (no location specified)
Nov 24, 2023
Galectin-3 in Papillary Thyroid Carcinoma
Not yet recruiting
- Galactin 3-thyroid Carcinoma
- (no location specified)
Jan 26, 2023
Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston
Recruiting
- Malignant Thyroid Gland Neoplasm
- +6 more
- Quality-of-Life Assessment
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jan 24, 2023
Tumor Deposits for Patients With Papillary Thyroid Carcinoma
Completed
- Exploring the Prognostic Value of Tumor Deposits PTC Patients
- surgery
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Sep 18, 2023
Thyroid Cancer, Surgery, Recurrence Trial in Beijing (Thyroxine)
Recruiting
- Thyroid Cancer
- +2 more
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Science
Oct 13, 2023
Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma
Completed
- Carcinoma, Renal Cell
- We do not have any interventions. This study is based on obseravation.
- (no location specified)
Oct 27, 2023
18F-TFB PET/CT Scan in Differentiated Thyroid Cancer
Recruiting
- Differentiated Thyroid Gland Carcinoma
- +2 more
- Computed Tomography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Benign Thyroid Gland Tumor, Recurrent Thyroid Gland Carcinoma, Thyroid Gland Follicular Tumor of Uncertain Malignant Potential
Recruiting
- Benign Thyroid Gland Neoplasm
- +4 more
- Quality-of-Life Assessment
- Radiofrequency Ablation
-
Houston, TexasM D Anderson Cancer Center
Sep 3, 2022
Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic
Active, not recruiting
- Columnar Cell Variant Thyroid Gland Papillary Carcinoma
- +25 more
- Laboratory Biomarker Analysis
- +3 more
-
Torrance, California
- +6 more
Jan 12, 2023
Carcinoma, Papillary, Follicular Trial in Seoul (Using Neuromonitoring to find EBSLN)
Terminated
- Carcinoma, Papillary, Follicular
- Using Neuromonitoring to find EBSLN
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 13, 2022
Fascial Versus Standard Neck Dissection in N1b Papillary Thyroid
Completed
- Patients With Papillary Thyroid Cancer and N1b Status
- Fascial Neck Dissection
- Standard Neck Dissection
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 27, 2023
Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma
Recruiting
- Refractory Thyroid Gland Carcinoma
- +3 more
- 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
- +2 more
-
Xiamen, ChinaThe First Affiliated Hospital of Xiamen University
Nov 3, 2022
RFA Treatment for Papillary Thyroid Microcarcinoma
Recruiting
- Papillary Thyroid Microcarcinoma
- Radiofrequency Ablation
-
New York, New YorkColumbia University
Dec 28, 2021
Predict Central Lymphnode Metastasis in Thyroid Papillary
Completed
- Thyroid Papillary Carcinoma
- male
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-Sen University
Dec 29, 2021
Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute
Not yet recruiting
- Advanced Clear Cell Renal Carcinoma (Ccrcc)
- Papillary Renal Cell Carcinoma (Prcc)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Papillary Thyroid Microcarcinoma Trial in Hong Kong (Echopulse)
Suspended
- Papillary Thyroid Microcarcinoma
- Echopulse
-
Hong Kong, Hong KongQueen Mary Hospital
May 17, 2022
A Gene Hunting Study for Familial Papillary Thyroid Cancer
Recruiting
- Thyroid
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 13, 2022
Papillary Thyroid Microcarcinoma, Thyroid Cancer Trial in Seoul (RFA for PTMC)
Recruiting
- Papillary Thyroid Microcarcinoma
- Thyroid Cancer
- RFA for PTMC
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 22, 2021
Papillary Thyroid Carcinoma Trial in Guangzhou (retro-auricular single-site endoscopic thyroidectomy, traditional open surgery
Recruiting
- Papillary Thyroid Carcinoma
- retro-auricular single-site endoscopic thyroidectomy
- traditional open surgery thyroidectomy
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Apr 17, 2022
Papillary Thyroid Carcinoma Trial in Guangzhou (Retro-Auricular Single-Site Endoscopic Thyroidectomy, Transoral Endoscopic
Recruiting
- Papillary Thyroid Carcinoma
- Retro-Auricular Single-Site Endoscopic Thyroidectomy
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Mar 6, 2023